Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01415375
Other study ID # R01CA104223
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received August 10, 2011
Last updated April 16, 2015
Start date September 2004
Est. completion date July 2009

Study information

Verified date April 2015
Source Temple University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study evaluates the efficacy of a tailored telephone intervention to promote informed decision making about prostate cancer testing among predominantly immigrant black men.


Description:

African American and African-Caribbean men have the greatest prostate cancer incidence and mortality rate. Professional organizations provide conflicting recommendations regarding prostate cancer testing but generally agree that men learn about the risks and benefits of testing and share in decisions about testing based on their personal preferences. This study was designed to assess the effects of a decision support intervention on men's knowledge about prostate cancer testing, participation in medical decisions about testing, decision conflict related to testing, and the congruence between prostate cancer testing intentions and behaviors. A randomized controlled trial was conducted. Participants were randomized into one of two conditions: (a) tailored telephone education about prostate cancer testing (intervention group) or (b) tailored telephone education about national guidelines for fruit and vegetable consumption (attention control group).


Recruitment information / eligibility

Status Completed
Enrollment 490
Est. completion date July 2009
Est. primary completion date July 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 45 Years to 70 Years
Eligibility Inclusion Criteria:

- 45 to 70 year old

- African descent

- accessible by telephone

- have primary care physician

Exclusion Criteria:

- Prostate cancer test in 12 months prior to enrollment

- History of prostate cancer

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening


Related Conditions & MeSH terms


Intervention

Behavioral:
Prostate Cancer Screening Education
tailored telephone education on prostate cancer testing
Fruit and Vegetable Intake Education
tailored telephone education about fruit and vegetable consumption

Locations

Country Name City State
United States Temple University Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Temple University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Lepore SJ, Wolf RL, Basch CE, Godfrey M, McGinty E, Shmukler C, Ullman R, Thomas N, Weinrich S. Informed decision making about prostate cancer testing in predominantly immigrant black men: a randomized controlled trial. Ann Behav Med. 2012 Dec;44(3):320-30. doi: 10.1007/s12160-012-9392-3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary congruence between prostate cancer testing intention and behavior Congruence between men's stated intentions to get tested and their actual testing behavior, validated by medical claims at 1 and 2 year follow-up. Intention-behavior agreement was coded as congruent (1), whereas disagreement was coded as incongruent (0). 1 and 2 years post randomization No
Primary Knowledge about prostate cancer and prostate cancer tests 12 item knowledge index with questions on testing, risk factors and epidemiology, and treatment effectiveness and side effects. Percent correct was used as the outcome measure. baseline and 8 months post randomization No
Primary Decisional conflict Used a modified version of the 16 item Decisional Conflict Scale with the 3 level response category suggested for low literacy populations. 8 months post randomization No
Primary Verified doctor visit to discuss prostate cancer testing Visit with physician to talk about prostate cancer testing, with visit verified through medical claims records 2 years post randomization No
Secondary State anxiety Used a 7 item subscale of the Hospital Anxiety and Depression Scale. baseline and 8 months post-randomization Yes